E3 ubiquitin protein ligase, E6-associated protein (E6-AP) regulates PI3K-Akt signaling and prostate cell growth

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1809, Issue 2, 2011, Pages 119-127

  Srinivasan, Sathish ^a   Nawaz, Zafar ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Androgen receptor; E6 AP; PI3K AKT; Prostate gland; RhoA

Indexed keywords

E6 ASSOCIATED PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN PHOSPHORYLATION; TRANSGENIC MOUSE;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; MALE; MICE; MICE, TRANSGENIC; PHOSPHATIDYLINOSITOL 3-KINASES; PRECANCEROUS CONDITIONS; PROSTATE; PROTO-ONCOGENE PROTEINS C-AKT; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

MUS MUSCULUS;

EID: 79251515465     PISSN: 18749399     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2010.08.011     Document Type: Article

References (28)

1. Khan O.Y., Fu G., Ismail A., Srinivasan S., Cao X., Tu Y., Lu S., Nawaz Z. Multifunction steroid receptor coactivator, E6-associated protein, is involved in development of the prostate gland. Mol. Endocrinol. 2006, 20:544-559.
2. Nawaz Z., Lonard D.M., Smith C.L., Lev-Lehman E., Tsai S.Y., Tsai M.J., O'Malley B.W. The Angelman syndrome-associated protein, E6-AP, is a coactivator for the nuclear hormone receptor superfamily. Mol. Cell. Biol. 1999, 19:1182-1189.
3. Huibregtse J.M., Scheffner M., Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. Embo J. 1991, 10:4129-4135.
4. Scheffner M., Huibregtse J.M., Howley P.M. Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl Acad. Sci. USA 1994, 91:8797-8801.
5. Scheffner M., Huibregtse J.M., Vierstra R.D., Howley P.M. The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 1993, 75:495-505.
6. Dhananjayan S.C., Ismail A., Nawaz Z. Ubiquitin and control of transcription. Essays Biochem. 2005, 41:69-80.
7. Ismail A., Nawaz Z. Nuclear hormone receptor degradation and gene transcription: an update. IUBMB Life 2005, 57:483-490.
8. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
9. Davies M.A., Koul D., Dhesi H., Berman R., McDonnell T.J., McConkey D., Yung W.K., Steck P.A. Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. Cancer Res. 1999, 59:2551-2556.
10. Graff J.R., Konicek B.W., McNulty A.M., Wang Z., Houck K., Allen S., Paul J.D., Hbaiu A., Goode R.G., Sandusky G.E., Vessella R.L., Neubauer B.L. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J. Biol. Chem. 2000, 275:24500-24505.
11. Malik S.N., Brattain M., Ghosh P.M., Troyer D.A., Prihoda T., Bedolla R., Kreisberg J.I. Immunohistochemical demonstration of phospho-Akt in high Gleason grade prostate cancer. Clin. Cancer Res. 2002, 8:1168-1171.
12. Murillo H., Huang H., Schmidt L.J., Smith D.I., Tindall D.J. Role of PI3K signaling in survival and progression of LNCaP prostate cancer cells to the androgen refractory state. Endocrinology 2001, 142:4795-4805.
13. Li L., Ittmann M.M., Ayala G., Tsai M.J., Amato R.J., Wheeler T.M., Miles B.J., Kadmon D., Thompson T.C. The emerging role of the PI3-K-Akt pathway in prostate cancer progression. Prostate Cancer Prostatic Dis. 2005, 8:108-118.
14. Tokunaga E., Kataoka A., Kimura Y., Oki E., Mashino K., Nishida K., Koga T., Morita M., Kakeji Y., Baba H., Ohno S., Maehara Y. The association between Akt activation and resistance to hormone therapy in metastatic breast cancer. Eur. J. Cancer 2006, 42:629-635.
15. Torres-Arzayus M.I., Font de Mora J., Yuan J., Vazquez F., Bronson R., Rue M., Sellers W.R., Brown M. High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene. Cancer Cell 2004, 6:263-274.
16. Xin L., Teitell M.A., Lawson D.A., Kwon A., Mellinghoff I.K., Witte O.N. Progression of prostate cancer by synergy of AKT with genotropic and nongenotropic actions of the androgen receptor. Proc. Natl Acad. Sci. USA 2006, 103:7789-7794.
17. Baron S., Manin M., Beaudoin C., Leotoing L., Communal Y., Veyssiere G., Morel L. Androgen receptor mediates non-genomic activation of phosphatidylinositol 3-OH kinase in androgen-sensitive epithelial cells. J. Biol. Chem. 2004, 279:14579-14586.
18. Castoria G., Migliaccio A., Bilancio A., Di Domenico M., de Falco A., Lombardi M., Fiorentino R., Varricchio L., Barone M.V., Auricchio F. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. Embo J. 2001, 20:6050-6059.
19. Guo R.X., Wei L.H., Tu Z., Sun P.M., Wang J.L., Zhao D., Li X.P., Tang J.M. 17 beta-estradiol activates PI3K/Akt signaling pathway by estrogen receptor (ER)-dependent and ER-independent mechanisms in endometrial cancer cells. J. Steroid Biochem. Mol. Biol. 2006, 99:9-18.
20. Sun M., Yang L., Feldman R.I., Sun X.M., Bhalla K.N., Jove R., Nicosia S.V., Cheng J.Q. Activation of phosphatidylinositol 3-kinase/Akt pathway by androgen through interaction of p85alpha, androgen receptor, and Src. J. Biol. Chem. 2003, 278:42992-43000.
21. Zhou G., Hashimoto Y., Kwak I., Tsai S.Y., Tsai M.J. Role of the steroid receptor coactivator SRC-3 in cell growth. Mol. Cell. Biol. 2003, 23:7742-7755.
22. Khan O.Y., Nawaz Z. Nuclear hormone receptor co-regulators. Curr. Opin. Drug Discov. Dev. 2003, 6:692-701.
23. Lonard D.M., O'Malley B.W. The expanding cosmos of nuclear receptor coactivators. Cell 2006, 125:411-414.
24. Zhou H.J., Yan J., Luo W., Ayala G., Lin S.H., Erdem H., Ittmann M., Tsai S.Y., Tsai M.J. SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res. 2005, 65:7976-7983.
25. Ghosh P.M., Bedolla R., Mikhailova M., Kreisberg J.I. RhoA-dependent murine prostate cancer cell proliferation and apoptosis: role of protein kinase Czeta. Cancer Res. 2002, 62:2630-2636.
26. Mani A., Oh A.S., Bowden E.T., Lahusen T., Lorick K.L., Weissman A.M., Schlegel R., Wellstein A., Riegel A.T. E6AP mediates regulated proteasomal degradation of the nuclear receptor coactivator amplified in breast cancer 1 in immortalized cells. Cancer Res. 2006, 66:8680-8686.
27. Freeman M.R., Cinar B., Lu M.L. Membrane rafts as potential sites of nongenomic hormonal signaling in prostate cancer. Trends Endocrinol. Metab. 2005, 16:273-279.
28. Heinlein C.A., Chang C. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. Mol. Endocrinol. 2002, 16:2181-2187.